News Headlines

  1. AGC Biologics Partners With Quell Therapeutics To Advance T-Regulatory Cell Therapies For Immune Disorders 5/15/2025

    AGC Biologics, your friendly CDMO expert, today announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage biotechnology company pioneering engineered T-regulatory (Treg) cell therapies.

  2. SK pharmteco Expands Stability Storage Capacity In California To Support Small Molecule Drug Substance And Drug Product Programs 5/15/2025

    SK pharmteco, a global contract development and manufacturing organization (CDMO), announces the expansion of its stability storage capacity at its El Dorado Hills, California facility.

  3. STEERLife Redefines Potent Drug Development With Clean, Green, Continuous Processing 5/15/2025

    STEERLife, the life sciences division of STEER World, is advancing the development and manufacturing of potent and complex drug products. This initiative marks a significant advancement in a field that has long been considered one of the most challenging areas within pharmaceutical science.

  4. Aldevron And Integrated DNA Technologies Manufacture World's First mRNA-Based Personalized CRISPR Therapy 5/15/2025

    Aldevron, a global leader in the production of DNA, RNA and protein, together with Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced the successful manufacture of the world’s first personalized CRISPR gene editing drug product to treat an infant with urea cycle disorder (UCD).

  5. Tivic Health Enters GMP Manufacturing Validation Agreement With Scorpius BioManufacturing In Preparation For FDA Submission 5/14/2025

     Tivic Health Systems, Inc., a diversified therapeutics company, announced today it has entered a definitive agreement with Scorpius BioManufacturing to complete the GMP manufacturing validation of the lead candidate from its TLR5 program, Entolimod, for treatment of Acute Radiation Syndrome, or ARS, in preparation for filing a Biological Licensing application, or BLA, with the U.S. Food & Drug Administration.

  6. 3PBIOVIAN Awarded At The CDMO Leadership Awards 2025 In The Cell & Gene Therapy International Category 5/14/2025
  7. 3PBIOVIAN Unveils Two Groundbreaking Technology Platforms For AAV And pDNA Manufacturing 5/14/2025

    3PBIOVIAN, a trusted CDMO partner in biopharmaceutical manufacturing proudly announced today the launch of AAVion® Platform, a fully integrated adeno-associated virus (AAV) manufacturing solution, designed to accelerate gene therapy development.

  8. Strategic Partnership With CMIC 5/14/2025

    Fette Compacting and CMIC CMO USA, a leading Contract Development and Manufacturing Organization (CDMO), are entering into a strategic cooperation.

  9. Asahi Kasei Bioprocess America And PeptiSystems Announce Global Partnership In Peptide Manufacturing—Streamlining The Peptide Processing Market 5/14/2025

    Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have announced a strategic, exclusive partnership aimed at delivering a streamlined process to the peptide manufacturing industry.

  10. Gummi World Enters Capsule Manufacturing, Emerging As The Most Agile Full-Spectrum Supplement Manufacturer In The Industry 5/14/2025

    Gummi World, the most certified gummy supplement manufacturer in the industry and a wholly owned subsidiary of Intiva Health Group, has officially launched high-volume capsule production, expanding its vertically integrated manufacturing platform to include both gummies and capsules under one certified roof.